Tiago Reis Marques's Insider Trades & SAST Disclosures

Tiago Reis Marques's most recent trade in Pasithea Therapeutics Corp was a trade of 960 Common Stock done at an average price of $0.8 . Disclosure was reported to the exchange on May 12, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Pasithea Therapeutics Corp
Tiago Reis Marques Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 0.82 per share. 12 May 2025 960 40,001 - 0.8 792 Common Stock
Pasithea Therapeutics Corp
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 15,000 15,000 - - Stock Option (right to buy)
Pasithea Therapeutics Corp
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 15,000 15,000 - - Stock Option (right to buy)
Pasithea Therapeutics Corp
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 11,669 11,669 - - Stock Option (right to buy)
Pasithea Therapeutics Corp
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 11,669 11,669 - - Stock Option (right to buy)
Pasithea Therapeutics Corp
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 1.00 per share. 23 Nov 2022 5,000 815,000 - 1 5,000 Common Stock
Pasithea Therapeutics Corp
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 1.03 per share. 23 Nov 2022 2,000 819,206 - 1.0 2,060 Common Stock
Pasithea Therapeutics Corp
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 1.02 per share. 23 Nov 2022 1,206 817,206 - 1.0 1,230 Common Stock
Pasithea Therapeutics Corp
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 1.03 per share. 23 Nov 2022 1,000 816,000 - 1.0 1,030 Common Stock
Pasithea Therapeutics Corp
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 1.07 per share. 21 Oct 2022 4,400 810,000 - 1.1 4,708 Common Stock
Pasithea Therapeutics Corp
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 1.08 per share. 21 Oct 2022 600 805,600 - 1.1 648 Common Stock
Pasithea Therapeutics Corp
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.99 per share. 23 Jun 2022 2,900 802,900 - 1.0 2,880 Common Stock
Pasithea Therapeutics Corp
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.99 per share. 23 Jun 2022 1,800 805,000 - 1.0 1,789 Common Stock
Pasithea Therapeutics Corp
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.98 per share. 23 Jun 2022 200 803,100 - 1.0 196 Common Stock
Pasithea Therapeutics Corp
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.99 per share. 23 Jun 2022 100 803,200 - 1.0 99 Common Stock
Pasithea Therapeutics Corp
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2021 200,000 800,000 - 0 Common Stock
Pasithea Therapeutics Corp
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2021 200,000 200,000 - - Stock Option (to acquire Common Stock)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades